Biomarkers and Genetic Alterations in Systemic Cancers and Brain Tumors

On behalf of the organizers, we would like to invite you to attend the 9^th Frye Halloran Symposium at Massachusetts General Hospital.  On November 5-6, 2009, a team of international experts will address the issue of novel assays of molecular targets in patients with systemic malignancies and brain tumors.  We invite you to attend this tuition-free meeting.

Speakers will address molecular targets of cancers of lung, breast and gastrointestinal origin as well as glioblastoma. Emphasis will be placed on common themes such as EGF amplification that appears in lung cancer and brain tumors; the evaluation of chromosomal and protein alterations in tumor patients, and the role of circulating tumor cells. A focus of the meeting will be the discussion of the novel identification of circulating  DNA and RNA molecular targets both in glioma and systemic cancers. Clearly the hope is to rapidly advance these technologies by incorporating them into clinical trials of molecularly targeted agents.

We ask that you explore our Website  http://fh2009.neurosuite.org  for more information.  If you wish to attend this free symposium please register on the website or contact Rita Gould at (617) 726-8657 or rgould2@partners.org.